| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |
,

*Department of Human Genetics, McGill University, Montreal, Quebec, Canada;
Department of Pathology, University of Otago, Dunedin, New Zealand;
Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
Correspondence to Dr. Paul Goodyer, McGill University Montreal Childrens Hospital, 2300 Tupper Street, Room E222A, Montreal, Quebec, Canada H3H 1P3. Phone: 514-412-4400 ext 22584; Fax: 514-412-4359; E-mail: Paul.Goodyer{at}muhc.mcgill.ca
ABSTRACT. In renal-coloboma syndrome (RCS), null mutations of the PAX2 gene cause renal hypoplasia due to a congenital deficit of nephrons; affected individuals may develop renal insufficiency in childhood. During normal kidney development, PAX2, is expressed at high levels throughout the arborizing ureteric bud (UB); recent observations suggest that one of its key roles is to suppress apoptosis in this collecting duct lineage. The authors hypothesized that increased UB cell apoptosis due to PAX2 haploinsufficiency must directly influence the rate of branching morphogenesis in developing kidney and the number of nephrons that can be formed before birth, when nephrogenesis in humans comes to an end. If so, the authors reasoned that caspase inhibitors might be used to suppress unwanted UB cell apoptosis during kidney development in Pax21Neu mutant mice and rescue the genetic UB branching defect. E17.5 kidneys from Pax21Neu mutant mice had smaller (-25%) longitudinal cross-sectional area and 3.5-fold increase in collecting duct cell apoptosis versus wild-type littermates; mutant E13.5 kidney explants allowed to arborize for 50 h in vitro had 18% fewer terminal branches than wild-types. However, exposure to the caspase inhibitor, Z-VAD-fmk (25 µM), significantly increased terminal branch number in mutant explants (23%). It also increased branching in wild-type explants, apparently reflecting an effect of Z-VAD-fmk on basal apoptosis induced by ex vivo culture conditions. Similarly, when pregnant mice were injected daily with Z-VAD-fmk (10 µg/g weight from E10.5 to E17.5), apoptosis of Pax21Neu fetal collecting duct cells was suppressed to 40% of untreated mutants; by E14, terminal branch number was increased to 152% that of untreated litters. These studies support the hypothesis that PAX2 normally optimizes the rate of branching morphogenesis in fetal kidney by suppressing UB apoptosis. Furthermore, it suggests that caspase inhibitors can rescue the branching defect caused by PAX2 mutations.
This article has been cited by other articles:
![]() |
I. J. Murawski, D. B. Myburgh, J. Favor, and I. R. Gupta Vesico-ureteric reflux and urinary tract development in the Pax21Neu+/ mouse Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1736 - F1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Quinlan, M. Lemire, T. Hudson, H. Qu, A. Benjamin, A. Roy, E. Pascuet, M. Goodyer, C. Raju, Z. Zhang, et al. A Common Variant of the PAX2 Gene Is Associated with Reduced Newborn Kidney Size J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1915 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cohen, O. Loutochin, M. Amin, J.-P. Capolicchio, P. Goodyer, and R. Jednak PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1267 - F1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stayner, D. M. Iglesias, P. R. Goodyer, L. Ellis, G. Germino, J. Zhou, and M. R. Eccles Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease Hum. Mol. Genet., December 15, 2006; 15(24): 3520 - 3528. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Park, H. Jia, V. Rajakumar, and H. M. Chamberlin Pax2/5/8 proteins promote cell survival in C. elegans Development, November 1, 2006; 133(21): 4193 - 4202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dziarmaga, P.-A. Hueber, D. Iglesias, N. Hache, A. Jeffs, N. Gendron, A. MacKenzie, M. Eccles, and P. Goodyer Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2 Am J Physiol Renal Physiol, October 1, 2006; 291(4): F913 - F920. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Torban, A. Dziarmaga, D. Iglesias, L. L. Chu, T. Vassilieva, M. Little, M. Eccles, M. Discenza, J. Pelletier, and P. Goodyer PAX2 Activates WNT4 Expression during Mammalian Kidney Development J. Biol. Chem., May 5, 2006; 281(18): 12705 - 12712. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fletcher, M. Hu, Y. Berman, F. Collins, J. Grigg, M. McIver, H. Juppner, and S. I. Alexander Multicystic Dysplastic Kidney and Variable Phenotype in a Family with a Novel Deletion Mutation of PAX2 J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2754 - 2761. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi, P. G. Gillespie, and A. L. Nuttall Na+ influx triggers bleb formation on inner hair cells Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1332 - C1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cai, N. I. Dmitrieva, J. D. Ferraris, H. L. Brooks, B. W. M. van Balkom, and M. Burg Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance PNAS, January 11, 2005; 102(2): 503 - 508. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673